GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-0126 |
Adipose tissue
|
PAXgene |
0
|
2 pieces, ~30-40% peripheral nerve, fascia, and vascular elements, rep delineated
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-0226 |
Skin, leg
|
PAXgene |
0
|
6 pieces; trace dermal fat; squamous epithelium is ~35-40 microns
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-0326 |
Nerve - tibial
|
PAXgene |
0
|
2 pieces, no adherent fat
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-0426 |
Minor salivary glands
|
PAXgene |
0
|
2 pieces, ~50% glandular elements, delineated; sample with care
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-0526 |
Muscle, skeletal
|
PAXgene |
0
|
2 pieces, trace interstitial fat
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-0626 |
Artery - tibial
|
PAXgene |
0
|
2 pieces, no significant atherosis or adherent fat
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-0726 |
Mammary tissue (breast)
|
PAXgene |
0
|
2 pieces, fibroadipose elements only
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-0826 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, multinodular goitre; regressive changes
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-0926 |
Lung
|
PAXgene |
1
|
1 piece; pronounced edema; moderate-marked septal fibrosis
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-1026 |
Atrial appendage
|
PAXgene |
1
|
2 pieces, no abnormalities
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-1226 |
Heart
|
PAXgene |
1
|
2 pieces, pronounced interstitial fibrosis/chronic ischemic changes
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-1326 |
Aorta
|
PAXgene |
1
|
6 pieces, calcifying (rep encircled) atherosis up to ~0.8mm
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-1426 |
Liver
|
PAXgene |
1
|
2 pieces, moderate macrovesicular steatosis and bridging fibrosis approaching early cirrhosis
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-1526 |
Spleen
|
PAXgene |
2
|
2 pieces, moderate congestion
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-1626 |
Omentum
|
PAXgene |
1
|
2 pieces, fragmented, ~10% fascia/mesothelial hyperplasia
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-1726 |
Kidney - cortex
|
PAXgene |
3
|
6 pieces, glomeruli present in 3; advanced autolysis
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-1826 |
Pancreas
|
PAXgene |
2
|
2 pieces, moderate-advanced saponification; islets barely visible, advanced degradation
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-1926 |
Adrenal glands
|
PAXgene |
3
|
2 pieces, cortex, advanced autolysis; ~15-20% adherent fat, delineated
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-2026 |
Gastroesophageal junction
|
PAXgene |
1
|
6 pieces, confirmed target muscularis; ~10% 'contaminant' squamous mucosa, rep delineated
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-2126 |
Stomach
|
PAXgene |
2
|
6 pieces, mucosa up to ~1mm, 50-70% thickness, moderately-advanced autolysis
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-2226 |
Esophagus - mucosa
|
PAXgene |
1
|
6 pieces, squamous mucosa up to ~0.4mm, ~15-20% thickness
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-2326 |
Esophagus - muscularis
|
PAXgene |
2
|
6 pieces; confirmed target muscularis
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-2526 |
Skin, suprapubic
|
PAXgene |
0
|
6 pieces, trace dermal fat, squamous epithelium is 30-45 microns
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-2626 |
Colon, transverse
|
PAXgene |
3
|
6 pieces, target mucosa up to ~0.4mm, ~20-25% thickness. Glandular elements sloughed, lamina propria only
|
Acceptable
|
 |
GTEX-1QMI2
|
61-70
|
Male
|
GTEX-1QMI2-2726 |
Colon, sigmoid
|
PAXgene |
2
|
6 pieces, target muscularis is ~50-605 of tissue, rep delineated.
|
Acceptable
|
 |